As highlighted on the UVA Cancer Center Facebook Page:
Stefanie Redemann, PhD, investigates cellular division – the fundamental process
for bodily growth, maintenance and function – to understand why it can go wrong,
resulting in cancer.
Dr. Redemann uses an electron microscope that emits a focused beam of electrons
to create a detailed image of a specimen’s structure and composition. She
examines microtubules, which act like ropes used in a tug-of-war to pull DNA into
place during cell division.
UVA Cancer Center’s ultimate goal is known as “translational” research:
interdisciplinary study that translates into better cancer prevention, detection, and
treatment. The foundation of translational research is known as basic science: how
healthy bodies and cancer cells actually work. While “basic science” may seem out
of place in advanced cancer research, we still have much to learn about the
fundamentals of living systems, including cell communication and disease
development.
That’s what Dr. Redemann studies. Her work is part of translational science
because it could impact many areas of discovery across fields. By creating images
of cell structures during division, she provides a cornerstone for future medical
advances, improved predictions, and disease prevention, diagnosis and treatment.
“Understanding how something works in the first place helps us come up with
solutions for when something goes wrong,” she explained.
“We want everyone to understand the importance of basic science because
translational science and medicine are not possible without understanding the
basic mechanisms,” Dr. Redemann said.
Dr. Redemann’s cell division and microtubule research is essential to fighting
cancer by answering the questions of basic science.
To learn more about Dr. Redemann, click here:
https://lnkd.in/eY9DMmxS